<it>MYH </it>Gene Status in Polish FAP Patients without <it>APC </it>Gene Mutations

<p>Abstract</p> <p>Familial Adenomatous Polyposis (FAP) is an inheritable predisposition for the occurrence of numerous polyps in the large intestine. In about 50% of all patients, the occurrence of the disease is conditioned by heterozygotic mutations of the <it>APC </it&...

Full description

Bibliographic Details
Main Authors: Skrzypczak Marzena, Podralska Marta, Heinritz Wolfram, Froster Ursula G, Lipiński Daniel, Słomski Ryszard, Pławski Andrzej
Format: Article
Language:English
Published: BMC 2006-01-01
Series:Hereditary Cancer in Clinical Practice
Subjects:
Online Access:http://www.hccpjournal.com/content/4/1/43
_version_ 1828406212640636928
author Skrzypczak Marzena
Podralska Marta
Heinritz Wolfram
Froster Ursula G
Lipiński Daniel
Słomski Ryszard
Pławski Andrzej
author_facet Skrzypczak Marzena
Podralska Marta
Heinritz Wolfram
Froster Ursula G
Lipiński Daniel
Słomski Ryszard
Pławski Andrzej
author_sort Skrzypczak Marzena
collection DOAJ
description <p>Abstract</p> <p>Familial Adenomatous Polyposis (FAP) is an inheritable predisposition for the occurrence of numerous polyps in the large intestine. In about 50% of all patients, the occurrence of the disease is conditioned by heterozygotic mutations of the <it>APC </it>gene. Screening for genetic factors in persons without mutations in the <it>APC </it>gene led to the identification of homozygotic mutations of the <it>MYH </it>gene as the cause of the appearance of the polyposis form which is characterized by recessive heritability and a milder course than in the case of the classic form of the disease. The authors examined 90 persons from the DNA bank of patients with FAP from the Institute of Human Genetics of the Polish Academy of Sciences in Poznań in whom no mutations in the <it>APC </it>gene were detected. Two of the most frequent mutations of the <it>MYH </it>gene (Y165C and G382D) were found to be heterozygous in 13% of patients and no other mutations in this gene coding sequence were observed. In the group with heterozygotic occurrence of the mutation in the <it>MYH </it>gene, the disease phenotype was not milder in comparison with the entire examined group and the mean age of the disease manifestation was even lower. This observation allows one to conclude that the employed methods of mutation screening were correct and, in the case of the examined group, the mutation ratio of the <it>MYH </it>gene does not precondition the occurrence of the disease, but it cannot be excluded that it may modify its phenotype. The obtained results indicate that the criteria applied during the process of FAP qualification are more rigorous than those applied in other countries.</p>
first_indexed 2024-12-10T11:08:36Z
format Article
id doaj.art-3fd030f6381047d1828164a54a5fb694
institution Directory Open Access Journal
issn 1897-4287
language English
last_indexed 2024-12-10T11:08:36Z
publishDate 2006-01-01
publisher BMC
record_format Article
series Hereditary Cancer in Clinical Practice
spelling doaj.art-3fd030f6381047d1828164a54a5fb6942022-12-22T01:51:30ZengBMCHereditary Cancer in Clinical Practice1897-42872006-01-0141434710.1186/1897-4287-4-1-43<it>MYH </it>Gene Status in Polish FAP Patients without <it>APC </it>Gene MutationsSkrzypczak MarzenaPodralska MartaHeinritz WolframFroster Ursula GLipiński DanielSłomski RyszardPławski Andrzej<p>Abstract</p> <p>Familial Adenomatous Polyposis (FAP) is an inheritable predisposition for the occurrence of numerous polyps in the large intestine. In about 50% of all patients, the occurrence of the disease is conditioned by heterozygotic mutations of the <it>APC </it>gene. Screening for genetic factors in persons without mutations in the <it>APC </it>gene led to the identification of homozygotic mutations of the <it>MYH </it>gene as the cause of the appearance of the polyposis form which is characterized by recessive heritability and a milder course than in the case of the classic form of the disease. The authors examined 90 persons from the DNA bank of patients with FAP from the Institute of Human Genetics of the Polish Academy of Sciences in Poznań in whom no mutations in the <it>APC </it>gene were detected. Two of the most frequent mutations of the <it>MYH </it>gene (Y165C and G382D) were found to be heterozygous in 13% of patients and no other mutations in this gene coding sequence were observed. In the group with heterozygotic occurrence of the mutation in the <it>MYH </it>gene, the disease phenotype was not milder in comparison with the entire examined group and the mean age of the disease manifestation was even lower. This observation allows one to conclude that the employed methods of mutation screening were correct and, in the case of the examined group, the mutation ratio of the <it>MYH </it>gene does not precondition the occurrence of the disease, but it cannot be excluded that it may modify its phenotype. The obtained results indicate that the criteria applied during the process of FAP qualification are more rigorous than those applied in other countries.</p>http://www.hccpjournal.com/content/4/1/43MYHFamilial PolyposisPoland
spellingShingle Skrzypczak Marzena
Podralska Marta
Heinritz Wolfram
Froster Ursula G
Lipiński Daniel
Słomski Ryszard
Pławski Andrzej
<it>MYH </it>Gene Status in Polish FAP Patients without <it>APC </it>Gene Mutations
Hereditary Cancer in Clinical Practice
MYH
Familial Polyposis
Poland
title <it>MYH </it>Gene Status in Polish FAP Patients without <it>APC </it>Gene Mutations
title_full <it>MYH </it>Gene Status in Polish FAP Patients without <it>APC </it>Gene Mutations
title_fullStr <it>MYH </it>Gene Status in Polish FAP Patients without <it>APC </it>Gene Mutations
title_full_unstemmed <it>MYH </it>Gene Status in Polish FAP Patients without <it>APC </it>Gene Mutations
title_short <it>MYH </it>Gene Status in Polish FAP Patients without <it>APC </it>Gene Mutations
title_sort it myh it gene status in polish fap patients without it apc it gene mutations
topic MYH
Familial Polyposis
Poland
url http://www.hccpjournal.com/content/4/1/43
work_keys_str_mv AT skrzypczakmarzena itmyhitgenestatusinpolishfappatientswithoutitapcitgenemutations
AT podralskamarta itmyhitgenestatusinpolishfappatientswithoutitapcitgenemutations
AT heinritzwolfram itmyhitgenestatusinpolishfappatientswithoutitapcitgenemutations
AT frosterursulag itmyhitgenestatusinpolishfappatientswithoutitapcitgenemutations
AT lipinskidaniel itmyhitgenestatusinpolishfappatientswithoutitapcitgenemutations
AT słomskiryszard itmyhitgenestatusinpolishfappatientswithoutitapcitgenemutations
AT pławskiandrzej itmyhitgenestatusinpolishfappatientswithoutitapcitgenemutations